Multiple endogenous receptors for released growth factors and cytokines

The term Multiple endogenous receptors for released growth factors and cytokines refers to a collective group of cell-surface proteins that mediate the biological effects of signaling polypeptides involved in repair and inflammation. These receptors, primarily including receptor tyrosine kinases (RTKs) and cytokine receptors, are the primary targets for regenerative therapies such as platelet-rich plasma (PRP) and recombinant growth factors (Gurtner et al., Nature, 2008). Upon activation by ligands like PDGF, TGF-beta, or VEGF, these receptors initiate complex intracellular signaling pathways, including the PI3K/Akt and MAPK/ERK cascades, which drive cell proliferation, migration, and differentiation (Dhillon et al., Journal of Orthopaedic Surgery and Research, 2012). This target is not a single molecular entity but rather a functional category used to describe the pleiotropic mechanism of action of multi-factor biological treatments. In clinical settings, these receptors are targeted to accelerate wound healing and treat musculoskeletal injuries, though the lack of specificity presents challenges in standardizing therapeutic outcomes. Safety considerations are paramount, as overstimulation of these pathways can theoretically lead to pathological fibrosis or the promotion of pre-existing neoplastic cells (O'Shea et al., Nature Reviews Immunology, 2013). Consequently, while therapeutically relevant, this designation is considered a descriptive grouping rather than a specific pharmacological target.

Other names

Growth factor receptorsCytokine receptorsEndogenous signaling receptorsCell-surface receptors for regenerative factors

Activation of a diverse array of high-affinity cell-surface receptors (e.g., PDGFR, VEGFR, EGFR, and IL-receptors) by exogenous or endogenously released ligands, triggering intracellular signaling cascades such as MAPK/ERK, PI3K/Akt, and JAK/STAT to promote regenerative cellular activities.